Asia-Pacific Animal Health Market - Forecast to 2025

Table of Content

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION & SCOPE 28
1.2.1 INCLUSIONS AND EXCLUSIONS 28
1.3 MARKETS COVERED 29
FIGURE 1 APAC ANIMAL HEALTH MARKET 29
1.3.1 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 30
1.5 STAKEHOLDERS 31
1.6 LIMITATIONS 31
1.7 SUMMARY OF CHANGES 31

2 RESEARCH METHODOLOGY 32
2.1 RESEARCH APPROACH 32
FIGURE 2 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 33
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 34
FIGURE 3 PRIMARY SOURCES 34
2.1.2.1 Key data from primary sources 35
2.1.2.2 Key industry insights 36
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION 38
FIGURE 7 COUNTRY-LEVEL ANALYSIS OF THE APAC ANIMAL HEALTH MARKET 38
FIGURE 8 APPROACH 4: TOP-DOWN APPROACH 39
FIGURE 9 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 40
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE APAC ANIMAL HEALTH MARKET (2020-2025) 41
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 42
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET SHARE ASSUMPTIONS 43
2.5 ASSUMPTIONS FOR THE STUDY 43

3 EXECUTIVE SUMMARY 44
FIGURE 12 APAC ANIMAL HEALTH MARKET, BY PRODUCT TYPE, 2020 VS. 2025 (USD MILLION) 44
FIGURE 13 APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2020 VS. 2025 (USD MILLION) 45
FIGURE 14 APAC ANIMAL HEALTH MARKET, BY END-USER, 2020 VS. 2025 (USD MILLION) 45

4 PREMIUM INSIGHTS 46
4.1 APAC ANIMAL HEALTH MARKET OVERVIEW 46
FIGURE 15 EMERGING COUNTRIES TO OFFER GROWTH OPPORTUNITIES FOR MARKET PLAYERS 46
4.2 ASIA PACIFIC: ANIMAL HEALTH MARKET, BY PRODUCT TYPE AND END-USER (2019) 47
FIGURE 16 ANIMAL FARMS SEGMENT & FEED ADDITIVES ACCOUNTED FOR THE LARGEST MARKET SHARES IN 2019 47

5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 17 APAC ANIMAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
5.2.1 DRIVERS 49
5.2.1.1 Rising demand for animal-derived food products 49
FIGURE 18 COUNTRY-LEVEL CONSUMPTION OF ANIMAL DERIVED FOOD PRODUCTS (2020-2030), THOUSAND METRIC TONS 49
FIGURE 19 COUNTRY-LEVEL PRODUCTION OF ANIMAL DERIVED FOOD PRODUCTS (2020-2030), THOUSAND METRIC TONS 49
FIGURE 20 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN THE WORLD IN 2018 50
5.2.1.2 Increasing livestock population and growing awareness about animal health 50
TABLE 1 APAC LIVESTOCK POPULATION, IN MILLION, 2014-2018 51
FIGURE 21 CATTLE POPULATION IN ASIA PACIFIC COUNTRIES, 2018 (IN MILLION) 51
5.2.1.3 Growing frequency of animal disease outbreaks 52
TABLE 2 ANIMAL DISEASE OUTBREAK IN ASIA PACIFIC COUNTRIES (2009-2019) 52
5.2.2 RESTRAINTS 53
5.2.2.1 Restrictions on use of parasiticides in food-producing animals 53
5.2.2.2 Shift toward vegetarian diet 53
5.2.2.3 Rising vaccine storage cost 54
5.2.3 OPPORTUNITIES 54
5.2.3.1 Lucrative growth opportunities in India and China 54
5.2.3.2 Growth in companion animal ownership and rising adoption of pet health insurance 55
5.2.4 CHALLENGES 55
5.2.4.1 Growing resistance to parasiticides and antibiotics 55
TABLE 3 PARASITICIDES AND RESISTANT PARASITES 56
5.2.4.2 Diversity of parasite species 56
5.2.4.3 Inadequate surveillance and reporting systems of vaccines 56
5.2.4.4 High costs of feed additive leading to adoption of conventional feeding systems 57
5.2.5 INDUSTRY TRENDS 57
5.2.5.1 Innovations in animal healthcare products 57
TABLE 4 INNOVATIVE ANIMAL PHARMACEUTICAL TRENDS 58
5.2.5.2 Consolidation in animal health industry 58
TABLE 5 SOME MAJOR ACQUISITIONS IN ANIMAL HEALTH INDUSTRY (2017-2019) 59
5.3 COVID-19 HEALTH ASSESSMENT 59
5.4 COVID-19 ECONOMIC ASSESSMENT 60
5.5 ASSESSMENT OF COVID-19 IMPACT ON ECONOMIC SCENARIO 60
FIGURE 22 CRITERIA IMPACTING THE GLOBAL ECONOMY 60
FIGURE 23 SCENARIOS OF THE RECOVERY OF THE GLOBAL ECONOMY 62
5.6 ASSESSMENT OF IMPACT OF COVID-19 ON ECONOMIC SCENARIO PERTAINING TO APAC ANIMAL HEALTH MARKET 63
5.7 VALUE CHAIN ANALYSIS 63
FIGURE 24 APAC ANIMAL HEALTH MARKET: VALUE CHAIN ANALYSIS 64
5.8 ECOSYSTEM MARKET MAP 65
FIGURE 25 APAC ANIMAL HEALTH MARKET: ECOSYSTEM MARKET MAP 65

6 APAC ANIMAL HEALTH MARKET, BY PRODUCT 66
6.1 INTRODUCTION 67
TABLE 6 APAC ANIMAL HEALTH MARKET, BY PRODUCT TYPE 2018–2025 (USD MILLION) 67
6.2 GROWTH PROMOTERS 67
TABLE 7 APAC ANIMAL GROWTH PROMOTERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 68
TABLE 8 APAC ANIMAL GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 68
6.2.1 PROBIOTICS & PREBIOTICS 68
6.2.1.1 Restrictions on the use of antibiotics have promoted the growth of probiotics & prebiotics 68
TABLE 9 APAC PROBIOTICS & PREBIOTICS GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 69
6.2.2 ACIDIFIERS 69
6.2.2.1 Regulations on the use of antibiotics and wide applications in different food-producing animals are driving the use of acidifiers 69
TABLE 10 APAC ACIDIFIERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 70
6.2.3 PHYTOGENICS 70
6.2.3.1 Natural performance enhancement and antioxidative and disease defense properties support the use of phytogenics 70
TABLE 11 APAC PHYTOGENICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 71
6.2.4 FEED ENZYME GROWTH PROMOTERS 71
6.2.4.1 Feed enzymes segment is expected to benefit significantly due to the ban on antibiotics and hormones 71
TABLE 12 APAC FEED ENZYME GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 72
6.2.5 HORMONAL GROWTH PROMOTERS 72
6.2.5.1 Routine use of hormonal growth promoters in east Asian countries contribute to their market growth 72
TABLE 13 APAC HORMONAL GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 73
6.2.6 OTHER GROWTH PROMOTERS 73
TABLE 14 APAC OTHER GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 74
6.3 FEED ADDITIVES/NUTRITIONAL PRODUCTS 74
TABLE 15 APAC ANIMAL FEED ADDITIVES/NUTRITIONAL PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 74
TABLE 16 APAC ANIMAL FEED ADDITIVES/NUTRITIONAL PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 75
6.3.1 AMINO ACIDS 75
6.3.1.1 High nutritional benefits and low cost drive the growth of amino acids 75
TABLE 17 APAC AMINO ACIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 76
6.3.2 BINDERS 76
6.3.2.1 Binders increase productivity of animal derived products, leading to their market growth 76
TABLE 18 APAC BINDERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 76
6.3.3 VITAMINS 77
6.3.3.1 Rising importance of vitamins as a key constituent for metabolic functions in livestock is projected to drive the market 77
TABLE 19 APAC VITAMINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 77
6.3.4 MINERALS 77
6.3.4.1 Multiple functions of minerals in animals driving growth 77
TABLE 20 APAC MINERALS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 78
6.3.5 FEED ACIDIFIERS 78
6.3.5.1 Improvement in economic performance of livestock due to feed acidifiers expected to lead to market growth 78
TABLE 21 APAC FEED ACIDIFIERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 79
6.3.6 ANTIOXIDANTS 79
6.3.6.1 Reduced wastage and improved nutrition promote the growth of antioxidants 79
TABLE 22 APAC ANTIOXIDANTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 79
6.3.7 OTHER FEED ADDITIVES/NUTRITIONAL PRODUCTS 80
TABLE 23 APAC OTHER FEED ADDITIVES/NUTRITIONAL PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 80
6.4 VACCINES 81
TABLE 24 APAC ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION) 81
TABLE 25 APAC ANIMAL VACCINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 81
6.4.1 LIVE ATTENUATED VACCINE 82
6.4.1.1 Live attenuated vaccine accounted for the largest share of the APAC animal vaccine market in 2019 82
TABLE 26 APAC LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 82
6.4.2 INACTIVATED VACCINES 82
6.4.2.1 High cost and short-lasting immunity hinder the growth of inactivated vaccines 82
TABLE 27 APAC INACTIVATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 83
6.4.3 TOXOID VACCINES 83
6.4.3.1 Safety and stability of toxoid vaccines to lead to market growth 83
TABLE 28 APAC TOXOID VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 83
6.4.4 RECOMBINANT VACCINES 84
6.4.4.1 Advantages associated with recombinant vaccines driving their demand 84
TABLE 29 APAC RECOMBINANT VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 84
6.4.5 OTHER VACCINES 84
TABLE 30 APAC OTHER VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 85
6.5 PARASITICIDES 85
TABLE 31 APAC ANIMAL PARASITICIDES MARKET, BY TYPE, 2018–2025 (USD MILLION) 85
TABLE 32 APAC ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 86
6.5.1 ECTOPARASITICIDES 86
TABLE 33 APAC ANIMAL ECTOPARASITICIDES MARKET, BY TYPE, 2018–2025 (USD MILLION) 86
TABLE 34 APAC ANIMAL ECTOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 87
6.5.1.1 Pour-ons & spot-ons 87
6.5.1.1.1 Ease of application support the demand for pour-ons & spot-ons 87
TABLE 35 APAC ANIMAL ECTOPARASITICIDE POUR-ONS & SPOT-ONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 87
6.5.1.2 Oral tablets 88
6.5.1.2.1 High medication compliance and ease of administration are key growth drivers in this market 88
TABLE 36 APAC ANIMAL ORAL ECTOPARASITICIDE TABLETS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 88
6.5.1.3 Sprays 88
6.5.1.3.1 Low price and convenient handling drive market growth 88
TABLE 37 APAC ANIMAL ECTOPARASITICIDE SPRAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 89
6.5.1.4 Dips 89
6.5.1.4.1 The high popularity of dips ensures sustained end user demand 89
TABLE 38 APAC ANIMAL ECTOPARASITICIDE DIPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 90
6.5.1.5 Ear tags 90
6.5.1.5.1 Ear tags are highly effective in controlling flies around cattle 90
TABLE 39 APAC ANIMAL ECTOPARASITICIDE EAR TAGS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 90
6.5.1.6 Collars 91
6.5.1.6.1 Increasing prevalence of infections in companion animals drive the growth of collars 91
TABLE 40 APAC ANIMAL ECTOPARASITICIDE COLLARS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 91
6.5.1.7 Other ectoparasiticides 91
TABLE 41 APAC ANIMAL OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 92
6.5.2 ENDOPARASITICIDES 92
TABLE 42 APAC ANIMAL ENDOPARASITICIDES MARKET, BY TYPE, 2018–2025 (USD MILLION) 92
TABLE 43 APAC ANIMAL ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 93
6.5.2.1 Oral liquids 93
6.5.2.1.1 Increasing demand for meat and milk drives the growth of the oral liquids market 93
TABLE 44 APAC ANIMAL ORAL LIQUID ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 93
6.5.2.2 Oral solids 94
6.5.2.2.1 The emergence of internal parasitic infections in dogs is expected to drive the growth of the oral solids market 94
TABLE 45 APAC ANIMAL ORAL SOLID ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 94
6.5.2.3 Injectables 94
6.5.2.3.1 Injectables offer rapid results, which has supported their use 94
TABLE 46 APAC ANIMAL INJECTABLE ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 95
6.5.2.4 Feed additives 95
6.5.2.4.1 Feed additives can be administered to large numbers of animals at once 95
TABLE 47 APAC ANIMAL FEED ADDITIVES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 95
6.5.2.5 Other endoparasiticides 96
TABLE 48 APAC ANIMAL OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 96
6.5.3 ENDECTOCIDES 96
6.5.3.1 Multiple applications against several parasites drive the growth of endectocides 96
TABLE 49 PLAYERS IN THE ENDECTOCIDES MARKET 97
TABLE 50 APAC ANIMAL ENDECTOCIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 97
6.6 ANTIMICROBIALS & ANTIBIOTICS 97
TABLE 51 APAC ANIMAL ANTIMICROBIALS & ANTIBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 52 APAC ANIMAL ANTIMICROBIALS & ANTIBIOTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 98
6.6.1 TETRACYCLINES 99
6.6.1.1 Reduced cost is a key factor driving higher use of tetracyclines across emerging Asian countries 99
TABLE 53 APAC TETRACYCLINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 99
6.6.2 PENICILLINS 99
6.6.2.1 Rising incidences of zoonotic diseases in livestock animals expected to drive growth of penicillins 99
TABLE 54 APAC PENICILLINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 100
6.6.3 SULFONAMIDES 100
6.6.3.1 Reduced cost and multiple applications in livestock infections drive demand for sulfonamides in rural Asian regions 100
TABLE 55 APAC SULFONAMIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 101
6.6.4 MACROLIDES 101
6.6.4.1 Increasing production of cattle derived food products expected to drive the growth of macrolides 101
TABLE 56 APAC MACROLIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 101
6.6.5 AMINOGLYCOSIDES 102
6.6.5.1 Rising prevalence of animal-related diseases in rural regions of Asia Pacific expected to drive the demand for aminoglycosides 102
TABLE 57 APAC AMINOGLYCOSIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 102
6.6.6 CEPHALOSPORINS 102
6.6.6.1 Increasing adoption of pets in Asian countries expected to drive the growth of cephalosporins 102
TABLE 58 APAC CEPHALOSPORINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 103
6.6.7 OTHER ANTIBIOTICS & ANTIMICROBIALS 103
TABLE 59 APAC OTHER ANTIBIOTICS & ANTIMICROBIALS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 104
6.7 OTHER PHARMACEUTICALS 104
TABLE 60 APAC OTHER PHARMACEUTICALS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 104

7 APAC ANIMAL HEALTH MARKET, BY ANIMAL 105
7.1 INTRODUCTION 106
TABLE 61 APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION) 106
7.2 FOOD PRODUCING ANIMALS 106
TABLE 62 PER CAPITA CONSUMPTION OF MEAT IN MAJOR APAC COUNTRIES, (IN KG), 2019 107
TABLE 63 APAC ANIMAL HEALTH MARKET FOR FOOD PRODUCING ANIMALS, BY TYPE, 2018–2025 (USD MILLION) 107
TABLE 64 FOOD-PRODUCING ANIMAL, BY COUNTRY, 2018–2025 (USD MILLION) 108
7.2.1 CATTLE 108
7.2.1.1 Increasing beef consumption and milk production to drive the segment 108
TABLE 65 APAC ANIMAL HEALTH MARKET FOR CATTLE, BY COUNTRY, 2018–2025 (USD MILLION) 108
7.2.2 PIGS 109
7.2.2.1 Growing incidences of zoonotic diseases will require better health maintenance of pigs 109
TABLE 66 APAC ANIMAL HEALTH MARKET FOR PIGS, BY COUNTRY, 2018–2025 (USD MILLION) 109
7.2.3 POULTRY 109
7.2.3.1 Growing egg consumption in emerging countries to drive the segment 109
FIGURE 26 LEADING EGG PRODUCING COUNTRIES IN ASIA PACIFIC (NUMBER OF EGGS, IN BILLION), 2018 110
TABLE 67 APAC ANIMAL HEALTH MARKET FOR POULTRY, BY COUNTRY, 2018–2025 (USD MILLION) 110
7.2.4 SHEEP AND GOATS 111
7.2.4.1 Increasing population of sheep and goats is expected to drive the segment 111
TABLE 68 APAC ANIMAL HEALTH MARKET FOR SHEEP AND GOATS, BY COUNTRY, 2018–2025 (USD MILLION) 111
7.2.5 OTHER FOOD-PRODUCING ANIMALS 111
FIGURE 27 CONSUMPTION OF FISH AND FISH PRODUCTS PER YEAR IN ASIAN COUNTRIES, PER CAPITA (IN KG) 112
TABLE 69 APAC ANIMAL HEALTH MARKET FOR OTHER FOOD PRODUCING ANIMALS, BY COUNTRY, 2018–2025 (USD MILLION) 112
7.3 COMPANION ANIMALS 113
TABLE 70 APAC COMPANION ANIMAL MARKET, BY TYPE 2018–2025 (USD MILLION) 113
TABLE 71 APAC COMPANION ANIMAL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 114
7.3.1 DOGS 114
7.3.1.1 Growing adoption of dogs to drive the segment 114
FIGURE 28 GROWING POPULATION OF PET DOGS IN INDIA (MILLION) 114
TABLE 72 APAC ANIMAL HEALTH MARKET FOR DOGS, BY COUNTRY, 2018–2025 (USD MILLION) 115
7.3.2 CATS 115
7.3.2.1 Increasing adoption of cats in South Asia to drive the segment 115
TABLE 73 APAC ANIMAL HEALTH MARKET FOR CATS, BY COUNTRY, 2018–2025 (USD MILLION) 116
7.3.3 HORSES 116
7.3.3.1 Declining horse population demands adoption of health products 116
TABLE 74 APAC ANIMAL HEALTH MARKET FOR HORSES, BY COUNTRY, 2018–2025 (USD MILLION) 116
7.3.4 OTHER COMPANION ANIMALS 117
TABLE 75 APAC ANIMAL HEALTH MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2018–2025 (USD MILLION) 117
8 APAC ANIMAL HEALTH MARKET, BY END-USER 118
8.1 INTRODUCTION 119
TABLE 76 APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION) 119
8.2 ANIMAL FARMS 119
8.2.1 GROWING LIVESTOCK POPULATION IN DEVELOPING COUNTRIES TO DRIVE THE SEGMENT 119
TABLE 77 GROWTH IN PRODUCTION OF MEAT AND MILK IN ASIA, 2015–2030, BY REGION 120
TABLE 78 GROWTH IN CONSUMPTION OF MEAT AND MILK IN ASIA, 2015–2030, BY REGION 120
TABLE 79 GROWTH IN PRODUCTION OF LIVESTOCK COMMODITIES IN ASIA, THOUSAND TONNES,2017–2030 120
TABLE 80 APAC ANIMAL HEALTH MARKET FOR ANIMAL FARMS, BY COUNTRY, 2018–2025 (USD MILLION) 121
8.3 VETERINARY HOSPITALS & CLINICS 121
8.3.1 GROWING ANIMAL HEALTH AWARENESS WILL DRIVE THE SEGMENT 121
FIGURE 29 ASIA PACIFIC TO SHOW HIGHEST GROWTH RATE IN PET INDUSTRY BY 2022 122
TABLE 81 APAC ANIMAL HEALTH MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION) 123
8.4 HOMECARE 123
8.4.1 RISING PET OWNERSHIP RATES TO DRIVE THE SEGMENT 123
TABLE 82 APAC ANIMAL HEALTH MARKET FOR HOMECARE, BY COUNTRY, 2018–2025 (USD MILLION) 123

9 APAC ANIMAL HEALTH MARKET, BY COUNTRY 124
9.1 INTRODUCTION 125
FIGURE 30 APAC ANIMAL HEALTH MARKET: SNAPSHOT 126
9.1.1 CHINA 127
9.1.1.1 Increasing pork consumption and growing pet adoption to drive the market 127
FIGURE 31 CHINA: PROJECTED COMPANION ANIMAL POPULATION, 2018-2025 (MILLION) 127
FIGURE 32 CHINA: PROJECTED FOOD-PRODUCING ANIMAL POPULATION, 2018–2025 (MILLION) 128
FIGURE 33 INCREASING CONSUMPTION OF PORK PRODUCTS IN CHINA, PER CAPITA (IN KILOGRAMS) (2011–2020) 129
FIGURE 34 GROWING CATTLE PRODUCTION IN CHINA, PER THOUSAND HEAD, 2009–2020 129
TABLE 83 CHINA: ANIMAL FEED ADDITIVE MARKET, BY TYPE, 2018–2025 (USD MILLION) 130
TABLE 84 CHINA: ANIMAL GROWTH PROMOTER PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION) 130
TABLE 85 CHINA: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION) 130
TABLE 86 CHINA: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 87 CHINA: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 88 CHINA: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 89 CHINA: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION) 132
TABLE 90 CHINA: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION) 132
TABLE 91 CHINA: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018–2025 (USD MILLION) 132
TABLE 92 CHINA: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018–2025 (USD MILLION) 133
TABLE 93 CHINA: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION) 133
9.1.2 JAPAN 133
9.1.2.1 Rising awareness about zoonotic diseases is expected to drive the market 133
FIGURE 35 JAPAN: PROJECTED COMPANION ANIMAL POPULATION, 2018-2025 (MILLION) 134
FIGURE 36 JAPAN: PROJECTED FOOD-PRODUCING ANIMAL POPULATION, 2018–2025 (MILLION) 135
TABLE 94 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS) 135
TABLE 95 JAPAN: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 96 JAPAN: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 97 JAPAN: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 98 JAPAN: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 137
TABLE 99 JAPAN: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 137
TABLE 100 JAPAN: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 137
TABLE 101 JAPAN: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION) 138
TABLE 102 JAPAN: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION) 138
TABLE 103 JAPAN: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018–2025 (USD MILLION) 138
TABLE 104 JAPAN: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018–2025 (USD MILLION) 139
TABLE 105 JAPAN: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION) 139
9.1.3 INDIA 139
9.1.3.1 Large livestock population and increasing production and export capacities to drive the market 139
FIGURE 37 INDIA: PROJECTED COMPANION ANIMAL POPULATION, 2018–2025 (MILLION) 140
FIGURE 38 INDIA: PROJECTED FOOD-PRODUCING ANIMAL POPULATION, 2018–2025, (MILLION) 141
FIGURE 39 INCREASING LIVESTOCK AND POULTRY POPULATION IN INDIA, 2003–2019 (MILLION) 141
TABLE 106 INDIA: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 107 INDIA: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 108 INDIA: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 109 INDIA: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 143
TABLE 110 INDIA: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 143
TABLE 111 INDIA: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 143
TABLE 112 INDIA: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION) 144
TABLE 113 INDIA: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION) 144
TABLE 114 INDIA: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018–2025 (USD MILLION) 144
TABLE 115 INDIA: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018–2025 (USD MILLION) 145
TABLE 116 INDIA: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION) 145
9.1.4 AUSTRALIA 145
9.1.4.1 Increasing pet population is expected to drive the market 145
FIGURE 40 AUSTRALIA: PROJECTED COMPANION ANIMAL POPULATION, 2018–2025 (MILLION) 146
FIGURE 41 AUSTRALIA: PROJECTED FOOD-PRODUCING ANIMAL POPULATION, 2018–2025 (MILLION) 147
TABLE 117 AUSTRALIA: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION) 147
TABLE 118 AUSTRALIA: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION) 148
TABLE 119 AUSTRALIA: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION) 148
TABLE 120 AUSTRALIA: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 148
TABLE 121 AUSTRALIA: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 149
TABLE 122 AUSTRALIA: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 149
TABLE 123 AUSTRALIA: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION) 149
TABLE 124 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018-2025(USD MILLION) 150
TABLE 125 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018-2025 (USD MILLION) 150
TABLE 126 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018-2025(USD MILLION) 150
TABLE 127 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION) 151
9.1.5 REST OF ASIA PACIFIC 151
TABLE 128 ROAPAC: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION) 152
TABLE 129 ROAPAC: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION) 152
TABLE 130 ROAPAC: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION) 152
TABLE 131 ROAPAC: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 153
TABLE 132 ROAPAC: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 153
TABLE 133 ROAPAC: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION) 153
TABLE 134 ROAPAC: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION) 154
TABLE 135 ROAPAC APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018-2025(USD MILLION) 154
TABLE 136 ROAPAC APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018-2025(USD MILLION) 154
TABLE 137 ROAPAC APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018-2025(USD MILLION) 155
TABLE 138 ROAPAC: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION) 155
10 COMPETITIVE LANDSCAPE 156
10.1 INTRODUCTION 156
FIGURE 42 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND 2020 156
10.2 MARKET EVALUATION FRAMEWORK 157
FIGURE 43 MARKET EVALUATION FRAMEWORK: MARKET CONSOLIDATION THROUGH PARTNERSHIPS, COLLABORATIONS, ACQUISITIONS, AND AGREEMENTS IN 2019 157
10.3 PRODUCT PORTFOLIO MATRIX 158
10.3.1 PARASITICIDES 158
10.3.2 VACCINES 159
10.3.3 ANTIBIOTICS & ANTIMICROBIALS 160
10.3.4 FEED ADDITIVES & NUTRITIONAL PRODUCTS 161
10.3.5 GROWTH PROMOTERS 162
10.4 APAC ANIMAL HEALTH MARKET: GEOGRAPHICAL ASSESSMENT 163
FIGURE 44 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE APAC ANIMAL HEALTH MARKET (2019) 163
10.5 APAC ANIMAL HEALTH MARKET: R&D EXPENDITURE 164
FIGURE 45 R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL HEALTH MARKET (2019) 164
10.6 REVENUE ANALYSIS OF KEY MARKET PLAYERS 164
FIGURE 46 REVENUE ANALYSIS: APAC ANIMAL HEALTH MARKET 2019 165
10.7 VENDOR DIVE 165
10.7.1 STARS 165
10.7.2 EMERGING LEADERS 166
10.7.3 PERVASIVE 166
10.7.4 EMERGING COMPANIES 166
FIGURE 47 COMPETITIVE LEADERSHIP MAPPING: APAC ANIMAL HEALTH MARKET, 2019 167
10.8 MARKET SHARE ANALYSIS 168
FIGURE 48 ANIMAL HEALTH MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 168
10.9 COMPETITIVE SITUATIONS AND TRENDS 169
FIGURE 49 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES & APPROVALS ACCOUNTED FOR THE LARGEST SHARE OF THE TOTAL DEVELOPMENTS PURSUED BY MARKET PLAYERS BETWEEN 2017 & 2020 169
10.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS 170
TABLE 139 PRODUCT LAUNCHES AND ENHANCEMENTS (2017 – SEPTEMBER 2020) 170
10.9.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 170
TABLE 140 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–SEPTEMBER 2020) 170
10.9.3 MERGERS & ACQUISITIONS AND DIVESTITURES 171
TABLE 141 MERGERS & ACQUISITIONS, DIVESTITURES (2017–SEPTEMBER 2020) 171
10.9.4 EXPANSIONS 172
TABLE 142 EXPANSIONS (2017–SEPTEMBER 2020) 172

11 STARTUP MATRIX 173
11.1 COMPETITIVE LEADERSHIP MAPPING (SMES/STARTUP) 173
11.1.1 PROGRESSIVE COMPANIES 173
11.1.2 STARTING BLOCKS 173
11.1.3 RESPONSIVE COMPANIES 173
11.1.4 DYNAMIC COMPANIES 173
FIGURE 50 EMERGING PLAYERS VENDOR DIVE: EVALUATION OVERVIEW 174

12 COMPANY PROFILES 175
(Business Overview, Products Offered, Recent Developments, MnM View, Strategic Overview, Right To Win)*
12.1 BOEHRINGER INGELHEIM 175
FIGURE 51 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2019) 175
12.2 ELANCO ANIMAL HEALTH 180
FIGURE 52 ELANCO: COMPANY SNAPSHOT (2019) 180
12.3 MERCK ANIMAL HEALTH 187
FIGURE 53 MERCK: COMPANY SNAPSHOT (2019) 187
12.4 ZOETIS INC. 194
FIGURE 54 ZOETIS: COMPANY SNAPSHOT (2019) 194
12.5 VIRBAC 201
FIGURE 55 VIRBAC: COMPANY SNAPSHOT (2019) 201
12.6 VETOQUINOL S.A. 206
FIGURE 56 VETOQUINOL: COMPANY SNAPSHOT (2019) 206
12.7 PHIBRO ANIMAL HEALTH 211
FIGURE 57 PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2019) 211
12.8 CEVA SANT? ANIMALE 215
12.9 DECHRA PHARMACEUTICALS PLC. 219
FIGURE 58 DECHRA: COMPANY SNAPSHOT (2019) 219
12.10 KYORITSU SEIYAKO 222
12.11 TIANJIN RINGPU 225
12.12 CHINA ANIMAL HUSBANDRY 228
12.13 JINYU BIO-TECHNOLOGY 230
12.14 ZYDUS ANIMAL HEALTH 232
FIGURE 59 ZYDUS: COMPANY SNAPSHOT (2019) 232
12.15 HIPRA 235
12.16 ENDOVAC ANIMAL HEALTH 239
12.17 BOVICURE PHARMA 239
12.18 INDIAN IMMUNOLOGICALS LTD. 240
12.19 ASHISH LIFE SCIENCE (ALS) 241
12.20 LUTIM PHARMA 242
*Business Overview, Products Offered, Recent Developments, MnM View Strategic Overview, Right To Win might not be captured in case of unlisted companies.<